Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential.
Saved in:
| Title: | Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential. |
|---|---|
| Authors: | Chakraborty, Ashok1 (AUTHOR) ashok.chakraborty@allexcel.com, Diwan, Anil2 (AUTHOR), Chiniga, Vijetha1 (AUTHOR), Arora, Vinod1 (AUTHOR), Thakur, Yogesh1 (AUTHOR), Tatake, Jayant1 (AUTHOR), Pandey, Rajesh1 (AUTHOR), Holkar, Preetam1 (AUTHOR), Holkar, Neelam1 (AUTHOR) |
| Source: | PLoS ONE. 2/20/2026, Vol. 21 Issue 2, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0324811 |
